Prevalence and Predictors of Hepatic Steatosis in Patients with HIV/HCV Coinfection and the Impact of HCV Eradication-Reference-Cited by-同舟云学术

Prevalence and Predictors of Hepatic Steatosis in Patients with HIV/HCV Coinfection and the Impact of HCV Eradication

Published:2019-05 Issue:5 Volume:33 Page:197-206
ISSN:1087-2914
Container-title:AIDS Patient Care and STDs
language:en
Short-container-title:AIDS Patient Care and STDs

Author:

Chromy David¹²,Mandorfer Mattias¹²,Bucsics Theresa¹²,Schwabl Philipp¹²,Bauer David¹²,Scheiner Bernhard¹²,Schmidbauer Caroline¹²,Lang Gerold Felician²³,Szekeres Thomas⁴,Ferenci Peter¹,Trauner Michael¹,Reiberger Thomas¹²

Affiliation:

1. Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria.

2. Vienna HIV & Liver Study Group, Vienna, Austria.

3. Department of Dermatology, Medical University of Vienna, Vienna, Austria.

4. Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria.

Publisher

Mary Ann Liebert Inc

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health

Link

https://www.liebertpub.com/doi/pdf/10.1089/apc.2018.0333

Reference54 articles.

1. HIV transmission and high rates of late diagnoses among adults aged 50 years and over

2. Epidemiology of viral hepatitis and HIV co-infection

3. Advances in the management of HIV/HCV coinfection

4. Revisiting liver disease progression in HIV/HCV-coinfected patients: the influence of vitamin D, insulin resistance, immune status, IL28B and PNPLA3

5. HIV-HCV co-infected patients with low CD4+ cell nadirs are at risk for faster fibrosis progression and portal hypertension

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prevalence and predictors of hepatic steatosis among HIV patients with and without chronic hepatitis C;Egyptian Liver Journal;2024-06-07

2. PNPLA3 and TM6SF2 genetic variants and hepatic fibrosis and cirrhosis in Pakistani chronic hepatitis C patients: a genetic association study;BMC Gastroenterology;2022-08-26

3. HCC risk stratification after cure of hepatitis C in patients with compensated advanced chronic liver disease;Journal of Hepatology;2021-12

4. Disparities in Treatment with Direct-Acting Hepatitis C Virus Antivirals Persist Among Adults Coinfected with HIV and Hepatitis C Virus in US Clinics, 2010–2018;AIDS Patient Care and STDs;2021-10-01

5. Liver Fat, Adipose Tissue, and Body Composition Changes After Switching from a Protease Inhibitor or Efavirenz to Raltegravir;AIDS Patient Care and STDs;2021-09-01